Emma Cartmell

Managing Director @ Cappello Group

Emma Cartmell joined Cappello Group as Managing Director in 2017, following a 20-year career building, acquiring, selling and taking companies public. Ms. Cartmell has served in multiple C-level positions for both public and private companies and has deep expertise in the healthcare technology and technology-enabled healthcare services industries. Under her leadership and guidance, healthcare companies have created and bought to market successful products and services that have led to successful exits.

Prior to joining Cappello, Ms. Cartmell served as the COO of NantHealth, a $1B private equity fund where she built the team and led investments and acquisitions of more than 50 companies. Before that, Ms. Cartmell was the COO of Personalized Medicine at Abraxis BioScience where she prepared the company for sale and helped negotiate an 8x revenue sale to Celgene for $2.9B. Earlier in her career, she was VP of Healthcare Advanced Programs and Director of Business Development at SAIC where she held both P&L and revenue-generating responsibilities for a $500M healthcare business and assisted with SAIC’s IPO road show materials.

Ms. Cartmell has developed M&A strategies for public and private companies on both the buy and sell-side, with investment targets of up to $1B. She also advises the Morgan Stanley Equity Research team on the Digital Health Market. She personally invests in healthcare technology start-ups, both individually and as a member of the Central Texas Angel Network, and helps guide them towards successful exits through her extensive healthcare industry knowledge and relationships.

Ms. Cartmell serves on the boards of the following companies and industry associations: HIMSS North America (non-profit), Austin Healthcare Council (non-profit), Morgan Stanley’s Equity Expansion Fund and multiple start-ups, including B.Well, Care.Coach and Accordion Health (acquired in 2017). In 2013, Ms. Cartmell was appointed as an advisor to both the U.S. and British governments on healthcare technology trade and investment, and she presents regularly at Health DataPalooza on the international venture capital markets.

Ms. Cartmell was recently awarded the John. A Page Outstanding Service Award at HIMSS17 for her leadership in HIMSS and the Healthcare Industry. Ms. Cartmell holds a Masters of Science degree from King’s College London.